IPOPLUS

1,350.8

-22.4 -1.63%

18 Jun 2026

NSE Listed · Pharmaceuticals

Cipla Ltd. (CIPLA)

Volume: 23,311Avg Vol 1W: 2,18,657Avg Vol 1M: 5,71,41752W Range:1,165.71,673
₹1,350.8 1.63%
Market Cap₹1,12,194 Cr
Current Price₹1,350.8
Previous Close₹1,373.2
High / Low (52w)₹1,673 / ₹1,165.7
Volume23,311
Avg Vol (1W)2,18,657
Avg Vol (1M)5,71,417
Stock P/E25.47
Book Value₹426.24
Dividend Yield0.94%
ROE11.27%
ROA9.11%
Revenue (TTM)
Revenue Growth2.23%
Profit Margin14%
Total Debt₹117 Cr
Shares Outstanding81 Cr
Face Value₹2
EPS (TTM)₹6.87
P/B3.06
Debt / Equity0.02
50 DMA₹1,390.83
200 DMA₹1,324.25
Day change-1.63%
Price Chart
1,350.8 18.81% · 1Y
1665119395.4L
2025-10-21
2026-06-16

20-day avg volume: 5.9L shares

Pros
  • Company is almost debt-free.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹6,541 Cr₹7,074 Cr₹7,589 Cr₹6,957 Cr₹6,730 Cr₹7,073 Cr₹7,051 Cr₹6,694 Cr₹6,163 Cr₹6,604 Cr₹6,678 Cr₹6,329 Cr₹5,739 Cr₹5,810 Cr₹5,829 Cr₹5,375 Cr₹5,260 Cr₹5,479 Cr₹5,520 Cr₹5,504 Cr₹4,606 Cr₹5,169 Cr₹5,038 Cr₹4,346 Cr₹4,376 Cr
EBITDA₹720 Cr₹1,183 Cr₹1,867 Cr₹1,784 Cr₹1,518 Cr₹1,931 Cr₹1,804 Cr₹1,629 Cr₹1,277 Cr₹1,699 Cr₹1,620 Cr₹1,391 Cr₹962 Cr₹1,250 Cr₹1,126 Cr₹992 Cr₹523 Cr₹1,075 Cr₹1,034 Cr₹1,150 Cr₹571 Cr₹1,069 Cr₹965 Cr₹845 Cr₹381 Cr
Net Profit₹555 Cr₹676 Cr₹1,351 Cr₹1,298 Cr₹1,222 Cr₹1,571 Cr₹1,303 Cr₹1,178 Cr₹939 Cr₹1,056 Cr₹1,131 Cr₹996 Cr₹526 Cr₹801 Cr₹789 Cr₹686 Cr₹362 Cr₹729 Cr₹711 Cr₹715 Cr₹413 Cr₹748 Cr₹665 Cr₹578 Cr₹246 Cr
EPS6.868.3616.7216.0615.1219.4316.1214.5811.6213.071412.336.519.929.778.54.489.028.88.855.129.268.247.163.05
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹29,045 Cr₹28,409 Cr₹26,521 Cr₹23,229 Cr₹22,044 Cr₹19,426 Cr₹17,476 Cr
EBITDA₹5,554 Cr₹6,883 Cr₹5,987 Cr₹4,330 Cr₹3,782 Cr₹3,451 Cr₹2,376 Cr
Net Profit₹3,879 Cr₹5,273 Cr₹4,122 Cr₹2,802 Cr₹2,517 Cr₹2,405 Cr₹1,547 Cr
EPS4865.2451.0134.6931.1729.7919.16
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹42,496 Cr₹37,387 Cr₹32,718 Cr₹29,463 Cr₹27,101 Cr₹25,152 Cr₹23,663 Cr
Total Liabilities₹7,976 Cr₹6,098 Cr₹5,915 Cr₹5,750 Cr₹5,984 Cr₹6,566 Cr₹7,605 Cr
Equity₹34,520 Cr₹31,289 Cr₹26,802 Cr₹23,714 Cr₹21,117 Cr₹18,586 Cr₹16,057 Cr
Total Debt₹117 Cr₹12 Cr₹0 Cr₹0 Cr₹416 Cr₹1,203 Cr₹2,369 Cr
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹5,526 Cr₹6,673 Cr₹5,731 Cr₹4,540 Cr₹4,465 Cr₹4,793 Cr₹3,917 Cr
Investing₹-2,326 Cr₹-3,691 Cr₹-2,988 Cr₹-2,389 Cr₹-1,872 Cr₹-2,387 Cr₹104 Cr
Financing₹-1,234 Cr₹-1,293 Cr₹-1,200 Cr₹-958 Cr₹-1,600 Cr₹-1,240 Cr₹-2,949 Cr
Free Cash Flow₹5,526 Cr₹6,673 Cr₹5,731 Cr₹4,540 Cr₹4,465 Cr₹4,793 Cr₹3,917 Cr
Shareholding
Promoter 29.13% Institutions 54.36% Public 15.61%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search